Gulf Pharmaceutical Industries P.S.C., widely known as Julphar, is a prominent pharmaceutical company based in Ras Al Khaimah, United Arab Emirates. Specializing in the research, development, production, and marketing of pharmaceutical solutions, Julphar plays a crucial role in advancing healthcare across the Middle East and North Africa (MENA) region. The company manufactures an array of medical products including generics, branded generics, and over-the-counter pharmaceuticals, catering to various therapeutic categories such as cardiovascular, diabetes, gastrointestinal, and pain management. Julphar's state-of-the-art manufacturing facilities are equipped with cutting-edge technology to ensure high-quality standards, reinforcing its commitment to accessible healthcare. Significantly, Julphar contributes to the pharmaceutical supply chain by operating one of the largest producer zones in the region, with strong distribution networks that expand its reach to over fifty countries. By prioritizing innovation and sustainability, Julphar remains a key player in the pharmaceutical sector, continuing to influence health outcomes and medical practices both regionally and globally.